Old Web
English
Sign In
Acemap
>
authorDetail
>
Richard C. Walovitch
Richard C. Walovitch
Medicine
Pharmacology
Perfusion scanning
Perfusion
Clinical trial
4
Papers
80
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Blinded independent central reviews: The FDA weighs in
2013
Clinical Research and Regulatory Affairs
Richard C. Walovitch
Show All
Source
Cite
Save
Citations (0)
Detection of coronary artery disease with perfusion stress echocardiography using a novel ultrasound imaging agent: two Phase 3 international trials in comparison with radionuclide perfusion imaging
2009
European Journal of Echocardiography
Roxy Senior
Mark J. Monaghan
Michael L. Main
Jose Luis Zamorano
Klaus Tiemann
Luciano Agati
Neil J. Weissman
Allan L. Klein
Thomas H. Marwick
Masood. Ahmad
Anthony N. DeMaria
Miguel Zabalgoitia
Harald Becher
Sanjiv Kaul
James E. Udelson
Frans J. Th. Wackers
Richard C. Walovitch
Michael H. Picard
Show All
Source
Cite
Save
Citations (69)
Phase I and pharmacokinetic study of AI-850, a novel microparticle hydrophobic drug delivery system for paclitaxel.
2007
Clinical Cancer Research
Alain C. Mita
Anthony J. Olszanski
Richard C. Walovitch
Raymond P. Perez
Kathleen Mackay
David Tuck
Cecilia Simmons
Susan Hammond
Monica M. Mita
Muralidhar Beeram
Anne J. Stone
Eric K. Rowinsky
Lionel D. Lewis
Show All
Source
Cite
Save
Citations (11)
Status of SPECT brain perfusion agents
1995
Richard C. Walovitch
Show All
Source
Cite
Save
Citations (0)
1